Cesca Therapeutics Inc (KOOL)

3.52
NASDAQ : Health Care
Prev Close 3.52
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.41 / 4.84
Avg Volume 96.40K
Exchange NASDAQ
Shares Outstanding 9.90M
Market Cap 34.66M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

And a management shakeup helps push down NuVasive.

Cesca Therapeutics Announces Issuance Of New Cellular Processing Patent Poised To Revolutionize CAR-T Cell Manufacturing

Cesca Therapeutics Announces Issuance Of New Cellular Processing Patent Poised To Revolutionize CAR-T Cell Manufacturing

Next-generation automated technology isolates and harvests rare cell types with superior purity, recovery, and viability, and is well suited to the high production demands of immunotherapy drugs

Cesca Therapeutics Acquires The Cell Processing Systems Of SynGen Under Asset Acquisition Agreement

Cesca Therapeutics Acquires The Cell Processing Systems Of SynGen Under Asset Acquisition Agreement

Combined product portfolio strengthens Cesca's position as a leading developer of systems for automated manufacturing of cell-based therapeutics in immuno-oncology and other indications

Cesca Therapeutics To Announce Fiscal Third Quarter 2017 Financial Results On May 11, 2017

Conference Call to be Held at 4:30 p.m. EDT (1:30 p.m. PDT)

Cesca Therapeutics Highlights Promising Data For The Treatment Of Chronic Non-Healing Ulcers

Significant reduction in wound size observed in all treated patients using autologous platelet rich plasma

Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Reports First Quarter Fiscal 2017 Results And Provides Business Update

Cesca Therapeutics Reports First Quarter Fiscal 2017 Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

TheStreet Quant Rating: D- (Sell)